Taurine Protects Irinotecan-induced Muscle Dysfunction by Modulating Oxidative Stress and Endoplasmic Reticulum Stress in Human Skeletal Muscle Cells
Authors:
- 2 December 2024
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 44 (12) , 5371-5378
Abstract
Background/Aim: Irinotecan is a key component of standard first-line treatment for metastatic colorectal cancer. However, irinotecan-induced muscle dysfunction is a contributing factor to cancer cachexia. Here, we present the protective effect of taurine, a conditionally essential amino acid with great antioxidant properties, in attenuating muscle dysfunction induced by irinotecan. Materials and Methods: Irinotecan (20 μg/ml) was added to human skeletal muscle cells (HSkMCs) with or without pre-treatment of taurine (5 mM). The effects of taurine and irinotecan on the viability, cytotoxicity, and differentiation ability of HSkMC myoblasts were examined. The intracellular reactive oxygen species (ROS) and endoplasmic reticulum stress (ERS) were also monitored. Results: Irinotecan caused cytotoxicity of HSkMCs, while taurine pretreatment increased cell viability and inhibited adenylate kinase release significantly in both myoblasts and myotubes. During differentiation, taurine increased ROS clearance and preserved the myotube differentiation ability impaired by irinotecan. Irinotecan exposure resulted in the up-regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) and glucose-regulated protein 78 (GRP78). Taurine pretreatment could combat such irinotecan-induced ERS. Conclusion: The current in vitro study provides molecular evidence that taurine plays a beneficial role in protecting against irinotecan-induced muscle dysfunction by modulating oxidative stress and endoplasmic reticulum stress.Keywords
This publication has 22 references indexed in Scilit:
- Metastatic colorectal cancer: mechanisms and emerging therapeuticsTrends in Pharmacological Sciences, 2023
- Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle WastingAntioxidants & Redox Signaling, 2023
- Taurine induces upregulation of p53 and Beclin1 and has antitumor effect in human nasopharyngeal carcinoma cells in vitro and in vivoActa Histochemica, 2022
- Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and astheniaJournal of Cachexia, Sarcopenia and Muscle, 2020
- Pretreatment with taurine prevented brain injury and exploratory behaviour associated with administration of anticancer drug cisplatin in ratsBiomedicine & Pharmacotherapy, 2018
- Cancer-associated cachexiaNature Reviews Disease Primers, 2018
- Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responsesBioFactors, 2016
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2014
- Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human DiseaseAntioxidants & Redox Signaling, 2014
- NF-κB Regulation of YY1 Inhibits Skeletal Myogenesis through Transcriptional Silencing of Myofibrillar GenesMolecular and Cellular Biology, 2007